Pillar Pacific Capital Management’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-990
| Closed | -$138K | – | 324 |
|
|
2020
Q4 | $138K | Hold |
990
| – | – | 0.01% | 309 |
|
|
2020
Q3 | $150K | Hold |
990
| – | – | 0.01% | 293 |
|
|
2020
Q2 | $174K | Hold |
990
| – | – | 0.02% | 282 |
|
|
2020
Q1 | $141K | Buy |
+990
| New | +$141K | 0.02% | 260 |
|
|
2015
Q4 | – | Sell |
-43
| Closed | -$48K | – | 297 |
|
|
2015
Q3 | $48K | Hold |
43
| – | – | 0.01% | 288 |
|
|
2015
Q2 | $44K | Hold |
43
| – | – | 0.01% | 288 |
|
|
2015
Q1 | $44K | Sell |
43
-2
| -4% | -$2.05K | 0.01% | 288 |
|
|
2014
Q4 | $148K | Sell |
45
-1
| -2% | -$3.29K | 0.03% | 278 |
|
|
2014
Q3 | $133K | Hold |
46
| – | – | 0.02% | 294 |
|
|
2014
Q2 | $175K | Hold |
46
| – | – | 0.03% | 288 |
|
|
2014
Q1 | $250K | Buy |
46
+1
| +2% | +$5.44K | 0.05% | 243 |
|
|
2013
Q4 | $140K | Buy |
+45
| New | +$140K | 0.03% | 297 |
|